Motion Sickness: Clinical Trials

7 trials for Motion Sickness, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 37Completed 7

Follow Motion Sickness: new trials by email Literature Review of Motion Sickness trials Research Report on Motion Sickness

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness
Tradipitant, Placebo - Motion Sickness
Phase 3CompletedVanda Pharmaceuticals3162023-09-092025-04-04
Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
DPI-386 Nasal Gel, Placebo - Motion Sickness
Phase 3CompletedRepurposed Therapeutics, Inc.5032022-08-232023-03-21
Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
Tradipitant, Placebo - Motion Sickness
Phase 3CompletedVanda Pharmaceuticals3662021-11-152024-12-11
Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
DPI-386 Nasal Gel, Placebo - Motion Sickness
Phase 3CompletedRepurposed Therapeutics, Inc.1402021-06-142021-09-17
Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness
DPI-386 Nasal Gel, Placebos - Motion Sickness
Phase 3CompletedRepurposed Therapeutics, Inc.1022019-06-092019-12-03
Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects
Scopolamine, Placebo Nasal Gel - Motion Sickness
Phase 3CompletedRepurposed Therapeutics, Inc.982019-06-072023-05-06
The Prevention and Treatment of Nausea Associated With Motion Sickness
Scopolamine Nasal Gel, Placebo - Motion Sickness
Phase 3CompletedRepurposed Therapeutics, Inc.3002019-04-262019-12-03

Broader conditions

Pathological Conditions, Signs and Symptoms (7)  ·  Signs and Symptoms (7)

Interventions

Scopolamine (4)

Sponsors

Repurposed Therapeutics, Inc. (5)  ·  Vanda Pharmaceuticals (2)

Countries

United States (7)

Top investigators

David Helton (2)  ·  David R Helton (2)  ·  Dave Helton (1)

Results publications

PMID 42150111, PMID 40103934